Trial Profile
A clinical study of a combination drug for type2 diabetes -Using self-monitoring of blood glucose and meal tolerance test-
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Mitiglinide/voglibose (Primary) ; Mitiglinide
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 03 Sep 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 05 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 08 Feb 2012 New trial record